Bayan A. Alturkestani
Founder, President and CEO @Conan Therapeutic Corp
Signup · Get unlimited contacts
WORK HISTORY
Founder, President and CEO @Conan Therapeutic Corp
Philadelphia, PA, US
EDUCATION
Cornell University
Master of Engineering - MEng, Biomedical Engineering
Alsumou Private Schools
High School
Temple University
Intensive English Language Program , English language
College of Applied Medical Sciences at King Abdulaziz Specialist Hospital
Physical Therapy
Temple University
Undergraduate, Bioengineering
ABOUT BAYAN A. ALTURKESTANI
As a Founder, Chief Executive Officer and Chief technological Officer of ConanMedTech, I\'m making the major corporate decisions and leading the overall operations and resources. I collaborate with interdisciplinary teams and stakeholders to drive innovation and growth. I am also leading the technical strategy behind our saliva-based concussion diagnostic platform-designed for rapid, non-invasive detection in athletic, educational, and military settings. Core competencies include biodesign, strategic project management, and regulatory alignment with FDA standards, which have been integral to advancing our products from concept to pre-clinical stages. Areas of focus include securing funding, strategic partnerships, and refining prototypes for novel medical devices. Motivated by a strong commitment to improving healthcare solutions, I aim to bring diverse perspectives and foster a culture of collaboration to deliver impactful technologies to the market. With a strong foundation in concussion, TBI, CTE, Medical devices, biotechnology, and translational research, I\'ve overseen the journey from bench science to product innovation, shaping a solution that addresses a critical unmet need in brain injury diagnostics. Our patented biomarker model and proprietary device architecture are built to accelerate real-time concussion detection, reduce misdiagnosis, and support safer return-to-play decisions.Currently, we are actively engaging with healthcare investors and strategic partners to:Finalize product validation and regulatory pathway (FDA Class II)Advance clinical trials and early-market pilotsScale operations for deployment in high-risk environmentsIf you\'re passionate about transforming neurodiagnostics and improving patient outcomes through scalable MedTech innovation, I\'d love to connect.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.